EnlonActive Ingredient(s): Edrophonium
FDA Approved: * August 6, 1985
Pharm Company: * BAXTER HLTHCARE CORP
Category: Myasthenic Syndrome
Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon and Enlon (according to FDA Orange Book). Contents 1 Clinical uses 2 Chemistry 3 Pharmacokinetics 4 References 5 Further reading Clinical uses Edrophonium (by the so-called Tensilon test) is used to differentiate... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Enlon 10 mg/ml Intramuscular; Intravenous Injection, SolutionNDC: 67457-190
Mylan Institutional LLC